Ono, Shoya
Suzuki, Susumu
Kondo, Yutaro
Okubo, Ikuko
Goto, Mitsuo
Ogawa, Tetsuya
Kato, Hidefumi
Ito, Hideaki
Takahara, Taishi
Satou, Akira
Tsuzuki, Toyonori
Yoshikawa, Kazuhiro
Nagao, Toru
Ueda, Ryuzo
Article History
Received: 17 June 2022
Accepted: 19 October 2022
First Online: 15 December 2022
Competing interests
: RU received research funding from Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., and Kyowa Kirin Co., Ltd. TTsuzuki received remuneration from Chugai Pharmaceutical Co., Ltd. and AstraZeneca PLC as advisors. The other authors declare no competing interests.